Literature DB >> 31987838

Fatty acid metabolism in the progression and resolution of CNS disorders.

Jeroen F J Bogie1, Mansour Haidar1, Gijs Kooij2, Jerome J A Hendriks3.   

Abstract

Recent advances in lipidomics and metabolomics have unveiled the complexity of fatty acid metabolism and the fatty acid lipidome in health and disease. A growing body of evidence indicates that imbalances in the metabolism and level of fatty acids drive the initiation and progression of central nervous system (CNS) disorders such as multiple sclerosis, Alzheimer's disease, and Parkinson's disease. Here, we provide an in-depth overview on the impact of the β-oxidation, synthesis, desaturation, elongation, and peroxidation of fatty acids on the pathophysiology of these and other neurological disorders. Furthermore, we discuss the impact of individual fatty acids species, acquired through the diet or endogenously synthesized in mammals, on neuroinflammation, neurodegeneration, and CNS repair. The findings discussed in this review highlight the therapeutic potential of modulators of fatty acid metabolism and the fatty acid lipidome in CNS disorders, and underscore the diagnostic value of lipidome signatures in these diseases.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Central nervous system; Immunometabolism; Lipids; Neurodegeneration; Neuroinflammation; Remyelination

Year:  2020        PMID: 31987838     DOI: 10.1016/j.addr.2020.01.004

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  16 in total

1.  The expression discrepancy and characteristics of long non-coding RNAs in peripheral blood leukocytes from amyotrophic lateral sclerosis patients.

Authors:  Yujiao Yu; Dejiang Pang; Chunyu Li; Xiaojing Gu; Yongping Chen; Ruwei Ou; Qianqian Wei; Huifang Shang
Journal:  Mol Neurobiol       Date:  2022-04-02       Impact factor: 5.590

Review 2.  Fatty acids role in multiple sclerosis as "metabokines".

Authors:  Haojun Yu; Shuwei Bai; Yong Hao; Yangtai Guan
Journal:  J Neuroinflammation       Date:  2022-06-17       Impact factor: 9.587

Review 3.  Role of Citicoline in the Management of Traumatic Brain Injury.

Authors:  Julio J Secades
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-26

4.  ADIPOR1 deficiency-induced suppression of retinal ELOVL2 and docosahexaenoic acid levels during photoreceptor degeneration and visual loss.

Authors:  Hideto Osada; Eriko Toda; Kohei Homma; Naymel A Guzman; Norihiro Nagai; Mamoru Ogawa; Kazuno Negishi; Makoto Arita; Kazuo Tsubota; Yoko Ozawa
Journal:  Cell Death Dis       Date:  2021-05-07       Impact factor: 8.469

Review 5.  Gut peptides and the microbiome: focus on ghrelin.

Authors:  Natasha K Leeuwendaal; John F Cryan; Harriët Schellekens
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2021-04-01       Impact factor: 3.626

Review 6.  The Role of Sphingolipids and Specialized Pro-Resolving Mediators in Alzheimer's Disease.

Authors:  Nienke M de Wit; Kevin Mol; Sabela Rodríguez-Lorenzo; Helga E de Vries; Gijs Kooij
Journal:  Front Immunol       Date:  2021-01-29       Impact factor: 7.561

7.  Proteomic and lipidomic profiling of demyelinating lesions identifies fatty acids as modulators in lesion recovery.

Authors:  Horst Penkert; Alix Bertrand; Vini Tiwari; Stephan Breimann; Stephan A Müller; Paul M Jordan; Mathias J Gerl; Christian Klose; Ludovico Cantuti-Castelvetri; Mar Bosch-Queralt; Ilya Levental; Stefan F Lichtenthaler; Oliver Werz; Mikael Simons
Journal:  Cell Rep       Date:  2021-10-26       Impact factor: 9.423

8.  Fatty Acid Synthase Is the Key Regulator of Fatty Acid Metabolism and Is Related to Immunotherapy in Bladder Cancer.

Authors:  Qiao Xiong; Dechao Feng; Ziwei Wang; Yidie Ying; Chuanliang Xu; Qiang Wei; Shuxiong Zeng; Lu Yang
Journal:  Front Immunol       Date:  2022-03-22       Impact factor: 7.561

9.  Cross-sectional analysis of plasma and CSF metabolomic markers in Huntington's disease for participants of varying functional disability: a pilot study.

Authors:  Andrew McGarry; John Gaughan; Cory Hackmyer; Jacqueline Lovett; Mohammed Khadeer; Hamza Shaikh; Basant Pradhan; Thomas N Ferraro; Irving W Wainer; Ruin Moaddel
Journal:  Sci Rep       Date:  2020-11-24       Impact factor: 4.996

10.  Pro-resolving lipid mediator lipoxin A4 attenuates neuro-inflammation by modulating T cell responses and modifies the spinal cord lipidome.

Authors:  Claudio Derada Troletti; Gaby Enzmann; Valerio Chiurchiù; Alwin Kamermans; Silvia Martina Tietz; Paul C Norris; Neda Haghayegh Jahromi; Alessandro Leuti; Susanne M A van der Pol; Marijn Schouten; Charles N Serhan; Helga E de Vries; Britta Engelhardt; Gijs Kooij
Journal:  Cell Rep       Date:  2021-06-01       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.